UN Agencies Encourage Use Of WTO Measures To Lower HIV Medicines Costs
Three United Nations agencies have joined together to explain to their member countries the little-understood but hard-won flexibilities to applying stiff international intellectual property rules. The focus of the new policy brief is on improving access to HIV treatment, and it offers a series of actions for governments and international organisations.

The use of arbitration across the Caribbean has been largely within the context of trade union disputes and is still something of a novelty in resolving commercial and private disputes in the region, Abiola Inniss writes.
On the eve of a meeting of the WHO working group on substandard/spurious/falsely-labelled/falsified/counterfeit medical products, research-based pharmaceutical industry group IFPMA sets out thoughts on building global consensus to address fake medicines.